Hawaii Biotech

Publications

Manoff SB, George SL, Bett AJ, Yelmene ML, Dhanasekaran G, Eggemeyer L, Sausser ML, Dubey SA, Casimiro DR, Clements DE, Martyak T, Pai V, Parks DE, Coller BA.  2015. 
Preclinical and clinical development of a dengue recombinant subunit vaccine.
Vaccine. 10;33(50):7126 34.

Govindarajana D, Meschinoa S, Guana L, Clements DE, ter Meulen JH, Casimiro DR, Coller BA, Bett AJ.  2015. 
Preclinical development of a dengue tetravalent recombinant subunit vaccine: Immunogenicity and protective efficacy in nonhuman primates.
Vaccine. 33(33):4105-16

Jarvi SI, Hu D, Misajon K, Coller B-A, Wong T, and Lieberman MM.  2013. 
Vaccination of captive Nene (Brant sandvicensis) against West Nile Virus using a protein-based vaccine (WN-80E).
Journal Wildlife Diseases 49:152-156

Pusic KM, Hashimoto CN, Lehrer A, Aniya C, Clements DE, Hui GS.  2011. 
T cell epitope regions of the P. falciparum MSP1-33 critically influence immune responses and in vitro efficacy of MSP1-42 vaccines.
PLoS One.;6(9):e24782.

Coller BA, Clements DE, Bett AJ, Sagar SL, Ter Meulen JH.  2011. 
The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease.
Vaccine 29:7267-7275.

Coller BA, Clements DE.  2011. 
Dengue vaccines: progress and challenges.
Current Opinion in Immunology 23(3):391-8.

Coller BA.  2010. 
A normal life in science.
Human Vaccines 6(7):528-31.

Clements DE, Coller BA, Lieberman MM, Ogata S, Wang G, Harada KE, Putnak JR, Ivy JM, McDonell M, Bignami GS, Peters ID, Leung J, Weeks-Levy C, Nakano ET, Humphreys T.  2010. 
Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys.
Vaccine. 28(15):2705-15.

Coller BA, Clements DE, Martyak T, Yelmene M, Thorne M, Parks DE.  2010. 
Advances in flavivirus vaccine development.
IDrugs. 13(12):880-4.

Lieberman MM, Nerurkar VR, Luo H, Cropp B, Carrion R Jr, de la Garza M, Coller BA, Clements D, Ogata S, Wong T, Martyak T, Weeks-Levy C.  2009. 
Immunogenicity and protective efficacy of a recombinant subunit West Nile virus vaccine in rhesus monkeys.
Clin. Vaccine Immunol. 16(9):1332-1337.

Siirin MT, Travassos da Rosa AP, Newman P, Weeks-Levy C, Coller BA, Xiao SY, Lieberman MM, Watts DM.  2008. 
Evaluation of the efficacy of a recombinant subunit West Nile vaccine in Syrian golden hamsters.
Am J Trop Med Hyg. Dec;79(6):955-62.

Jarvi SI, Lieberman MM, Hofmeister E, Nerurkar VR, Wong T, and Weeks-Levy C.  2008. 
Protective efficacy of a recombinant subunit West Nile virus vaccine in domestic geese (Anser anser).
Vaccine 26:5338-5344.

Nagata M, Wong T, Clements D, Hui G.  2007. 
Plasmodium falciparum: immunization with MSP1-42 induced non-inhibitory antibodies that have no blocking activities but enhanced the potency of inhibitory anti-MSP1-42 antibodies.
Exp Parasitol. Apr;15(4):403-8.

Lieberman MM, Clements DE, Ogata S, Wang G, Corpuz G, Wong T, Martyak T, Gilson L, Coller B, Leung J, Watts DM, Tesh RB, Siirin M, Travassos da Rosa A, Humphreys T, Weeks-Levy C.  2007. 
Preparation and immunogenic properties of a recombinant West Nile subunit vaccine.
Vaccine, 25:414-423.

Watts DM, Tesh RB, Siirin M, Travassos da Rosa A, Newman PC, Clements DE, Ogata S, Coller B, Weeks-Levy C, Lieberman MM.  2007. 
Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis.
Vaccine, 25:2913-2918.

Modis Y, Ogata S, Clements D, Harrison SC.  2005. 
Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein.
J Virol. 79(2):1223-31.

Putnak RJ, Coller BA, Voss G, Vaughn DW, Clements D, Peters I, Bignami G, Houng HS, Chen RC, Barvir DA, Seriwatana J, Cayphas S, Garcon N, Gheysen D, Kanesa-Thasan N, McDonell M, Humphreys T, Eckels KH, Prieels JP, Innis BL.  2005. 
An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model.
Vaccine 23(35):4442-52.

Zhang Y, Zhang W, Ogata S, Clements D, Strauss JH, Baker TS, Kuhn RJ, Rossmann MG.  2004. 
Conformational changes of the flavivirus E glycoprotein.
Structure (Camb). 12(9):1607-18.

Modis Y, Ogata S, Clements D, Harrison SC,  2004.  
Structure of the dengue virus envelope protein after membrane fusion.
Nature, 427(6972):313-319.

Modis Y, Ogata S, Clements D, Harrison SC,  2003.  
A ligand-binding pocket in the dengue virus envelope glycoprotein.
Proceedings of the National Academy of Sciences of the USA, 100(12): 6986-6991.

Gramer MJ, Maas J, Lieberman MM,  2003. 
Use of hollow fiber systems for rapid and direct scale up of antibody production from hybridoma cell lines cultured in CL-1000 flasks using BD Cell Mab medium.
Cytotechnology 42:155-162.

Cuzzubbo AJ, Endy TP, Nisalak A, Kalayanarooj S, Vaughn DW, Ogata SA, Clements DE, Devine PL, 2001.   
Use of recombinant envelope proteins for serological diagnosis of Dengue virus infection in an immunochromatographic assay.
Clinical and diagnostic laboratory immunology, 8(6): 1150-1155.

 


Employee Email Employee Email